NCT07469202 2026-03-13CYTALUX Dose Extension StudyOn Target Laboratories, LLCPhase 4 Not yet recruiting106 enrolled
NCT07418749 2026-02-18A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical CancerSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 Not yet recruiting398 enrolled